Publications & Recent Presentations
Upcoming and Recent Presentations
ASN Kidney Week 2023 -- Philadelphia, PA
Comprehensive evaluation of CKD heat map
Lead Presenter: Morgan Grams
Session Title: Epidemiology of CKD Progression: Who, Why, and When? [OR2301]
Session Date/Time: November 4, 2023 from 4:30 PM to 6:00 PM
Session Room: Room 119 (Pennsylvania Convention Center)
Abstract Publication #: SA-OR35
Presentation Time: 5:33 PM to 5:42 PM
ASN Kidney Week 2022 -- Orlando, FL
Risk Prediction: CKD Staging Is the Beginning, Not the End
Lead Presenter: Morgan Grams
November 3, 2022 - Location: West Exhibit Hall E
Time: 10:00 AM - 12:00 PM
Poster Presentation TH-PO890
ASN Kidney Week 2023 -- Philadelphia, PA
Comprehensive evaluation of CKD heat map
Lead Presenter: Morgan Grams
Session Title: Epidemiology of CKD Progression: Who, Why, and When? [OR2301]
Session Date/Time: November 4, 2023 from 4:30 PM to 6:00 PM
Session Room: Room 119 (Pennsylvania Convention Center)
Abstract Publication #: SA-OR35
Presentation Time: 5:33 PM to 5:42 PM
ASN Kidney Week 2022 -- Orlando, FL
Risk Prediction: CKD Staging Is the Beginning, Not the End
Lead Presenter: Morgan Grams
November 3, 2022 - Location: West Exhibit Hall E
Time: 10:00 AM - 12:00 PM
Poster Presentation TH-PO890
Publications
1. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Chronic Kidney Disease Prognosis Consortium, Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, Coresh J, Gansevoort RT. Lancet 2010 Jun 12;375(9731): 2073-81. (PubMed)
2. Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. van der Velde M, Matsushita K, Coresh J, Astor BC, Woodward M, Levey A, de Jong P, Gansevoort RT; the Chronic Kidney Disease Prognosis Consortium. Kidney Int 2011 Jun;79(12): 1341-52.(PubMed)
3. Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. Gansevoort RT, Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, Jong PE, Coresh J; the Chronic Kidney Disease Prognosis Consortium. Kidney Int 2011 Jul;80(1): 93-104. (PubMed)
4. Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts. Astor BC, Matsushita K, Gansevoort RT, van der Velde M, Woodward M, Levey AS, Jong PE, Coresh J; the Chronic Kidney Disease Prognosis Consortium. Kidney Int 2011 Jun;79(12): 1331-40. (PubMed)
5. Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. Matsushita K, Mahmoodi BK, Woodward M, Emberson JR, Jafar TH, Jee SH, Polkinghorne KR, Shankar A, Smith DH, Tonelli M, Warnock DG, Wen CP, Coresh J, Gansevoort RT, Hemmelgarn BR, Levey AS; the Chronic Kidney Disease Prognosis Consortium. JAMA 2012 May 9;307(18): 1941-51. (PubMed)
6. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis. Mahmoodi BK, Matsushita K, Woodward M, Blankestijn PJ, Cirillo M, Ohkubo T, Rossing P, Sarnak MJ, Stengel B, Yamagishi K, Yamashita K, Zhang L, Coresh J, de Jong, PE, Astor BD; the Chronic Kidney Disease Prognosis Consortium. Lancet 2012 Nov 10;380(9854): 1649-61. (PubMed)
7. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. Fox C, Matsushita K, Woodward M, Bilo HJ, Chalmers J, Lambers Heerspink HJ, Lee BJ, Perkins RM, Rossing P, Sairenchi T, Tonelli M, Vassalotti JA, Yamagishi K, Coresh J, de Jong PE, Wen CP, Nelson RG; the Chronic Kidney Disease Prognosis Consortium. Lancet 2012 Nov 10;380(9854): 1662-73. (PubMed)
8. Age and association of kidney measures with mortality and end-stage renal disease. Hallan SI, Matsushita K, Sang Y, Mahmoodi BK, Black C, Ishani A, Kleefstra N, Naimark D, Roderick P, Tonelli M, Wetzels JF, Astor BC, Gansevoort RT, Levin A, Wen CP, Coresh J; the Chronic Kidney Disease Prognosis Consortium. JAMA 2012 Dec 12;308(22): 2349-60. (PubMed)
9. Associations of estimated glomerular filtration rate and albuminuria with mortality and renal failure by sex: a meta-analysis. Nitsch D, Grams M, Sang Y, Black C, Cirillo M, Djurdjev O, Iseki K, Jassal SK, Kimm H, Kronenberg F, Oien CM, Levey AS, Levin A, Woodward M, Hemmelgarn BR; the Chronic Kidney Disease Prognosis Consortium. BMJ 2013 Jan 29;346: f324. (PubMed)
10. Cystatin C versus creatinine in determining risk based on kidney function. Shlipak MG, Matsushita K, Arnlov J, Inker LA, Katz R, Polkinghorne KR, Rothenbacher D, Sarnak MJ, Astor BC, Coresh J, Levey AS, Gansevoort RT; the Chronic Kidney Disease Prognosis Consortium. NEJM 2013 Sept 5;369(10): 932-43. (PubMed)
11. Relative risks of chronic kidney disease for mortality and end-stage renal disease across races are similar. Wen CP, Matsushita K, Coresh J, Iseki K, Islam M, Katz R, McClellan W, Peralta CA, Wang H, de Zeeuw D, Astor BC, Gansevoort RT, Levey AS, Levin A; the Chronic Kidney Disease Prognosis Consortium. Kidney Int 2014 Oct;86(4): 819-27. (PubMed)
12. Decline in Estimated Glomerular Filtration Rate and Subsequent Risk of End-Stage Renal Disease and Mortality. Coresh J, Turin TC, Matsushita K, Sang Y, Ballew SH, Appel LJ, Arima H, Chadban SJ, Cirillo M, Djurdjev O, Green JA, Heine GH, Inker LA, Irie F, Ishani A, Ix JH, Kovesdy CP, Marks A, Ohkubo T, Shalev V, Shankar A, Wen CP, de Jong PE, Iseki K, Stengel B, Gansevoort RT, Levey AS; the Chronic Kidney Disease Prognosis Consortium. JAMA 2014 June 25;311(24): 2518-31. (PubMed)
13. A Meta-analysis of the Association of Estimated GFR, Albuminuria, Age, Race, and Sex With Acute Kidney Injury. Grams ME, Sang Y, Ballew SH, Gansevoort RT, Kimm H, Kovesdy CP, Naimark D, Oien C, Smith DH, Coresh J, Sarnak MJ, Stengel B, Tonelli M; the Chronic Kidney Disease Prognosis Consortium. AJKD 2015 Oct;66(4): 591-601. (PubMed)
14. A Meta-analysis of the Association of Estimated GFR, Albuminuria, Diabetes Mellitus, and Hypertension With Acute Kidney Injury. James MT, Grams ME, Woodward M, Elley CR, Green JA, Wheeler DC, de Jong P, Gansevoort RT, Levey AS, Warnock DG, Sarnak MJ; the Chronic Kidney Disease Prognosis Consortium. AJKD 2015 Oct;66(4): 602-612 (PubMed)
15. Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data. Matsushita K, Coresh J, Sang Y, Chalmers J, Fox C, Guallar E, Jafar T, Jassal SK, Landman GW, Muntner P, Roderick P, Sairenchi T, Schöttker B, Shankar A, Shlipak M, Tonelli M, Townend J, van Zuilen A, Yamagishi K, Yamashita K, Gansevoort R, Sarnak M, Warnock DG, Woodward M, Ärnlöv J; the Chronic Kidney Disease Prognosis Consortium. Lancet Diabetes Endocrinol 2015 Jul;3(7): 514-525. (PubMed)
16. Kidney-Failure Risk Projection for the Living Kidney-Donor Candidate. Grams ME, Sang Y, Levey AS, Matsushita K, Ballew S, Chang AR, Chow EK, Kasiske BL, Kovesdy CP, Nadkarni GN, Shalev V, Segev DL, Coresh J, Lentine KL, Garg AX; the Chronic Kidney Disease Prognosis Consortium. NEJM 2016 Feb 4;374(5):411-21. (PubMed)
17. Past Decline Versus Current eGFR and Subsequent ESRD Risk. Kovesdy CP, Coresh J, Ballew SH, Woodward M, Levin A, Naimark DM, Nally J, Rothenbacher D, Stengel B, Iseki K, Matsushita K, Levey AS; the Chronic Kidney Disease Prognosis Consortium. J Am Soc Nephrol 2016 Aug;27(8):2447-55. (PubMed)
18. Past Decline Versus Current eGFR and Subsequent Mortality Risk. Naimark DM, Grams ME, Matsushita K, Black C, Drion I, Fox CS, Inker LA, Ishani A, Jee SH, Kitamura A, Lea JP, Nally J, Peralta CA, Rothenbacher D, Ryu S, Tonelli M, Yatsuya H, Coresh J, Gansevoort RT, Warnock DG, Woodward M, de Jong PE; the Chronic Kidney Disease Prognosis Consortium. J Am Soc Nephrol 2016 Aug;27(8):2456-66. (PubMed)
19. Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure: A Meta-analysis. Tangri N, Grams ME, Levey AS, Coresh J, Appel LJ, Astor BC, Chodick G, Collins AJ, Djurdjev O, Elley CR, Evans M, Garg AX, Hallan SI, Inker LA, Ito S, Jee SH, Kovesdy CP, Kronenberg F, Heerspink HJ, Marks A, Nadkarni GN, Navaneethan SD, Nelson RG, Titze S, Sarnak MJ, Stengel B, Woodward M, Iseki K; the Chronic Kidney Disease Prognosis Consortium. JAMA 2016 Jan 12; 315(2): 164-174. (PubMed)
20. Measures of chronic kidney disease and risk of incident peripheral artery disease: a collaborative meta-analysis of individual participant data. Matsushita K, Ballew SH, Coresh J, Arima H, Ärnlöv J, Cirillo M, Ebert N, Hiramoto JS, Kimm H, Shlipak MG, Visseren FLJ, Gansevoort RT, Kovesdy CP, Shalev V, Woodward M, Kronenberg F; Chronic Kidney Disease Prognosis Consortium. Lancet Diabetes Endocrinol 2017 Sep;5(9):718-728. (PubMed)
21. Serum potassium and adverse outcomes across the range of kidney function: a CKD Prognosis Consortium meta-analysis. Kovesdy CP, Matsushita K, Sang Y, Brunskill NJ, Carrero JJ, Chodick G, Hasegawa T, Heerspink HL, Hirayama A, Landman GWD, Levin A, Nitsch D, Wheeler DC, Coresh J, Hallan SI, Shalev V, Grams ME; Chronic Kidney Disease Prognosis Consortium. Eur Heart J 2018 May 1;39(17):1535-1542. (PubMed)
22. Predicting timing of clinical outcomes in patients with chronic kidney disease and severely decreased glomerular filtration rate. Grams ME, Sang Y, Ballew SH, Carrero JJ, Djurdjev O, Heerspink HJL, Ho K, Ito S, Marks A, Naimark D, Nash DM, Navaneethan SD, Sarnak M, Stengel B, Visseren FLJ, Wang AY, Kottgen A, Levey AS, Woodward M, Eckardt KU, Hemmelgarn B, Coresh J; Chronic Kidney Disease Prognosis Consortium. Kidney Int 2018 Mar; 93:1442-1451. (PubMed)
23. Risk Factors for Prognosis in Patients With Severely Decreased GFR. Evans M, Grams ME, Sang Y, Astor BC, Blankestijn PJ, Brunskill NJ, Collins JF, Kalra PA, Kovesdy CP, Levin A, Mark PB, Moranne O, Rao P, Rios PG, Schneider MP, Shalev V, Zhang H, Chang AR, Gansevoort RT, Matsushita K, Zhang L, Eckardt K-U, Hemmelgarn B, Wheeler DC; Chronic Kidney Disease Prognosis Consortium. Kidney Int Rep 2018;3:625-637. (PubMed)
24. Relationship of Estimated GFR and Albuminuria to Concurrent Laboratory Abnormalities: An Individual Participant Data Meta-analysis in a Global Consortium. Inker LA, Grams ME, Levey AS, Coresh J, Cirillo M, Collins JF, Gansevoort RT, Gutierrez OM, Hamano T, Heine GH, Ishikawa S, Jee SH, Kronenberg F, Landray MJ, Miura K, Nadkarni GN, Peralta CA, Rothenbacher D, Schaeffner E, Sedaghat S, Shlipak MG, Zhang L, van Zuilen AD, Hallan SI, Kovesdy CP, Woodward M, Levin A; Chronic Kidney Disease Prognosis Consortium. AJKD 2019;73(2):206-217. (PubMed)
25. Adiposity and risk of decline in glomerular filtration rate: meta-analysis of individual participant data in a global consortium. Chang AR, Grams ME, Ballew SH, Bilo H, Correa A, Evans M, Gutierrez OM, Hosseinpanah F, Iseki K, Kenealy T, Klein B, Kronenberg F, Lee BJ, Li Y, Miura K, Navaneethan SD, Roderick PJ, Valdivielso JM, Visseren FLJ, Zhang L, Gansevoort RT, Hallan SI, Levey AS, Matsushita K, Shalev V, Woodward M; Chronic Kidney Disease Prognosis Consortium. BMJ 2019;364:k5301. (PubMed)
26. Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies. Coresh J, Heerspink HJL, Sang Y, Matsushita K, Arnlov J, Astor BC, Black C, Brunskill NJ, Carrero J-J, Feldman HI, Fox CS, Inker LA, Ishani A, Ito S, Jassal S, Konta T, Polkinghorne K, Romundstad S, Solbu MD, Stempniewicz N, Stengel B, Tonelli M, Umesawa M, Waikar SS, Wen C-P, Wetzels JFM, Woodward M, Grams ME, Kovesdy CP, Levey AS, Gansevoort RT; Chronic Kidney Disease Prognosis Consortium. Lancet Diabetes Endocrinol 2019;7(2):115-127. (PubMed)
27. Evaluating Glomerular Filtration Rate Slope as a Surrogate End Point for ESKD in Clinical Trials: An Individual Participant Meta-Analysis of Observational Data. Grams ME, Sang Y, Ballew SH, Matsushita K, Astor BC, Carrero JJ, Chang AR, Inker LA, Kenealy T, Kovesdy CP, Lee BJ, Levin A, Naimark D, Pena MJ, Schold JD, Shalev V, Wetzels JFM, Woodward M, Gansevoort RT, Levey AS, Coresh J; Chronic Kidney Disease Prognosis Consortium. JASN 2019;30(9):1746-1755. (PubMed)
28. Development of Risk Prediction Equations for Incident Chronic Kidney Disease. Nelson RG, Grams ME, Ballew SH, Sang Y, Azizi F, Chadban SJ, Chaker L, Dunning SC, Fox C, Hirakawa Y, Iseki K, Ix J, Jafar TH, Köttgen A, Naimark DMJ, Ohkubo T, Prescott GJ, Rebholz CM, Sabanayagam C, Sairenchi T, Schöttker B, Shibagaki Y, Tonelli M, Zhang L, Gansevoort RT, Matsushita K, Woodward M, Coresh J, Shalev V; Chronic Kidney Disease Prognosis Consortium. JAMA 2019 Nov 8;322(21):2104-2114. (PubMed)
29. Conversion of Urine Protein-Creatinine Ratio or Urine Dipstick Protein to Urine Albumin-Creatinine Ratio for Use in Chronic Kidney Disease Screening and Prognosis : An Individual Participant-Based Meta-analysis. Sumida K, Nadkarni GN, Grams ME, Sang Y, Ballew SH, Coresh J, Matsushita K, Surapaneni A, Brunskill N, Chadban SJ, Chang AR, Cirillo M, Daratha KB, Gansevoort RT, Garg AX, Iacoviello L, Kayama T, Konta T, Kovesdy CP, Lash J, Lee BJ, Major RW, Metzger M, Miura K, Naimark DMJ, Nelson RG, Sawhney S, Stempniewicz N, Tang M, Townsend RR, Traynor JP, Valdivielso JM, Wetzels J, Polkinghorne KR, Heerspink HJL; Chronic Kidney Disease Prognosis Consortium. Ann Intern Med 2020 Sep 15;173(6):426-435. (PubMed)
30. Incorporating kidney disease measures into cardiovascular risk prediction: Development and validation in 9 million adults from 72 datasets. Matsushita K, Jassal SK, Sang Y, Ballew SH, Grams ME, Surapaneni A, Arnlov J, Bansal N, Bozic M, Brenner H, Brunskill NJ, Chang AR, Chinnadurai R, Cirillo M, Correa A, Ebert N, Eckardt K-U, Gansevoort RT, Gutierrez O, Hadaegh F, He J, Hwang S-J, Jafar TH, Kayama T, Kovesdy CP, Landman GW, Levey AS, Lloyd-Jones DM, Major RW, Miura K, Muntner P, Nadkarni GN, Naimark DMJ, Nowak C, Ohkubo T, Pena MJ, Polkinghorne KR, Sabanayagam C, Sairenchi T, Schneider MP, Shalev V, Shlipak M, Solbu MD, Stempniewicz N, Tollitt J, Valdivielso JM, van der Leeuw J, Wang AY-M, Wen C-P, Woodward M, Yamagishi K, Yatsuya H, Zhang L, Schaeffner E, Coresh J; Chronic Kidney Disease Prognosis Consortium. EClinicalMedicine 2020 Oct 14;27:100552. (PubMed)
31. Albuminuria Testing in Hypertension and Diabetes: An Individual-Participant Data Meta-Analysis in a Global Consortium.
Shin JI, Chang AR, Grams ME, Coresh J, Ballew SH, Surapaneni A, Matsushita K, Bilo HJG, Carrero JJ, Chodick G, Daratha KB, Jassal SK, Nadkarni GN, Nelson RG, Nowak C, Stempniewicz N, Sumida K, Traynor JP, Woodward M, Sang Y, Gansevoort RT; CKD Prognosis Consortium. Hypertension 2021 Sep;78(4):1042-1052. (PubMed)
32. Association of Estimated GFR Calculated Using Race-Free Equations With Kidney Failure and Mortality by Black vs Non-Black Race. Gutiérrez OM, Sang Y, Grams ME, Ballew SH, Surapaneni A, Matsushita K, Go AS, Shlipak MG, Inker LA, Eneanya ND, Crews DC, Powe NR, Levey AS, Coresh J; CKD Prognosis Consortium. JAMA 2022 Jun ;327(23):2306-2316. (PubMed)
33. Development and Validation of Prediction Models of Adverse Kidney Outcomes in the Population With and Without Diabetes Mellitus. Grams ME, Brunskill NJ, Ballew SH, Sang Y, Coresh J, Matsushita K, Surapaneni A, Bell S, Carrero JJ, Chodick G, Evans M, Heerspink HJL, Inker LA, Iseki K, Kalra PA, Kirchner HL, Lee BJ, Levin A, Major RW, Medcalf J, Nadkarni GN, Naimark DMJ, Ricardo AC, Sawhney S, Sood MM, Staplin N, Stempniewicz N, Stengel B, Sumida K, Traynor JP, van den Brand J, Wen CP, Woodward M, Yang JW, Wang AY, Tangri N; CKD Prognosis Consortium. Diabetes Care 2022 Sept;45(9):2055-2063. (PubMed)
34. Including Measures of Chronic Kidney Disease to Improve Cardiovascular Risk Prediction by SCORE2 and SCORE2-OP. Matsushita K, Kaptoge S, Hageman SH, Sang Y, Ballew SH, Grams ME, Surapaneni A, Sun L, Arnlov J, Bozic M, Brenner H, Brunskill NJ, Chang AR, Chinnadurai R, Cirillo M, Correa A, Ebert N, Eckardt KU, Gansevoort RT, Gutierrez O, Hadaegh F, He J, Hwang SJ, Jafar TH, Jassal SK, Kayama T, Kovesdy CP, Landman GW, Levey AS, Lloyd-Jones DM, Major RW, Miura K, Muntner P, Nadkarni GN, Nowak C, Ohkubo T, Pena MJ, Polkinghorne KR, Sairenchi T, Schaeffner E, Schneider MP, Shalev V, Shlipak MG, Solbu MD, Stempniewicz N, Tollitt J, Valdivielso JM, van der Leeuw J, Wang AYM, Wen CP, Woodward M, Yamagishi K, Yatsuya H, Zhang L, Dorresteijn JA, Di Angelantonio E, Visseren FL, Pennells L, Coresh J, Chronic Kidney Disease Prognosis Consortium. Eur J Prev Cardiol 2022 Aug Epub ahead of print. (PubMed)
35. The Kidney Failure Risk Equation: Evaluation of Novel Input Variables including eGFR Estimated Using the CKD-EPI 2021 Equation in 59 Cohorts. Grams ME, Brunskill NJ, Ballew SH, Sang Y, Coresh J, Matsushita K, Surapaneni A, Bell S, Carrero JJ, Chodick G, Evans M, Heerspink HJL, Inker LA, Iseki K, Kalra PA, Kirchner HL, Lee BJ, Levin A, Major RW, Medcalf J, Nadkarni GN, Naimark DMJ, Ricardo AC, Sawhney S, Sood MM, Staplin N, Stempniewicz N, Stengel B, Sumida K, Traynor JP, van den Brand J, Wen CP, Woodward M, Yang JW, Wang AY, Tangri N, Chronic Kidney Disease Prognosis Consortium. J Am Soc Nephrol 2023 Mar 1;34(3):482-494. (PubMed)
36. Estimated glomerular filtration rate, albuminuria and adverse outcomes. Grams ME, Coresh J, Matsushita K, Ballew SH, Sang Y, Surapaneni A, Alencar de Pinho N, Anderson A, Appel LJ, Ärnlöv J, Azizi F, Bansal N, Bell S, Bilo HJG, Brunskill NJ, Carrero JJ, Chadban S, Chalmers J, Chen J, Ciemins E, Cirillo M, Ebert N, Evans M, Ferreiro A, Fu EL, Fukagawa M, Green JA, Gutierrez OM, Herrington WG, Hwang SJ, Inker LA, Iseki K, Jafar T, Jassal SK, Jha V, Kadota A, Katz R, Köttgen A, Konta T, Kronenberg F, Lee BJ, Lees J, Levin A, Looker HC, Major R, Melzer Cohen C, Mieno M, Miyazaki M, Moranne O, Muraki I, Naimark D, Nitsch D, Oh W, Pena M, Purnell TS, Sabanayagam C, Satoh M, Sawhney S, Schaeffner E, Schöttker B, Shen JI, Shlipak MG, Sinha S, Stengel B, Sumida K, Tonelli M, Valdivielso JM, van Zuilen AD, Visseren FLJ, Wang AY, Wen CP, Wheeler DC, Yatsuya H, Yamagata K, Yang JW, Young A, Zhang H, Zhang L, Levey AS, Gansevoort RT, Chronic Kidney Disease Prognosis Consortium. JAMA 2023;330(13):1266-1277. (PubMed)
Consortium collaboration with the CKD Epidemiology Collaboration
New Creatinine- and Cystatin C–Based Equations to Estimate GFR without Race. Inker LA, Eneanya ND, Coresh J, Tighiouart H, Wang D, Sang Y, Crews DC, Doria A, Estrella MM, Froissart M, Grams ME, Greene T, Grubb A, Gudnason V, Gutierrez OM, Kalil R, Karger AB, Mauer M, Navis G, Nelson RG, Poggio ED, Rodby R, Rossing P, Rule AD, Selvin E, Seegmiller JC, Shlipak MG, Torres VE, Yang W, Ballew SH, Couture SJ, Powe NR, Levey AS. NEJM Nov 2021; 385:1737-1749. (PubMed)
Cohort Profile
Cohort Profile: The Chronic Kidney Disease Prognosis Consortium. Matsushita K, Ballew SH, Astor BC, Jong PE, Gansevoort RT, Hemmelgarn BR, Levey AS, Levin A, Wen CP, Woodward M, Coresh J. Int J Epidemiol 2013;42: 1660-1668. (PubMed)